STOCK TITAN

[Form 4] PAYCHEX INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Paychex (PAYX) reported an insider equity award on Form 4. A director acquired 725 shares of common stock via restricted stock units on 10/15/2025 at $0, increasing beneficial ownership to 79,344 shares directly.

The filing also shows a new stock option grant for 3,061 shares at an exercise price of $127.52 on 10/15/2025, first exercisable on 10/15/2026 and expiring on 10/14/2035. Existing option holdings remain outstanding across multiple grants, with exercise prices ranging from $57.20 to $140.68 and expirations extending through 2035. The RSU award is pursuant to the Amended and Restated 2002 Stock Incentive Plan.

Paychex (PAYX) ha riportato un premio azionario interno su Form 4. Un amministratore ha acquistato 725 azioni ordinarie tramite unità di azioni vincolate il 15/10/2025 a $0, aumentando la proprietà beneficiaria a 79.344 azioni direttamente.

La presentazione mostra anche una nuova assegnazione di opzione su azioni per 3.061 azioni a un prezzo di esercizio di $127,52 il 15/10/2025, primo esercizio il 15/10/2026 e scadenza il 14/10/2035. Le attuali posizioni in opzioni rimangono in essere su più premi, con prezzi di esercizio che vanno da $57,20 a $140,68 e scadenze fino al 2035. L’assegnazione RSU è conforme al Amended and Restated 2002 Stock Incentive Plan.

Paychex (PAYX) informó una adjudicación de acciones de insider en el Formulario 4. Un director adquirió 725 acciones comunes mediante unidades de acciones restringidas el 15/10/2025 a $0, aumentando la propiedad beneficiosa a 79.344 acciones directamente.

La presentación también muestra una nueva adjudicación de opciones sobre acciones por 3.061 acciones a un precio de ejercicio de $127,52 el 15/10/2025, primero ejercitable el 15/10/2026 y venciendo el 14/10/2035. Las tenencias existentes de opciones permanecen vigentes en múltiples adjudicaciones, con precios de ejercicio que van desde $57,20 hasta $140,68 y vencimientos que se extienden hasta 2035. El premio RSU se otorga de conformidad con el Amended and Restated 2002 Stock Incentive Plan.

Paychex (PAYX)가 Form 4에서 내부 주식 보상을 보고했습니다. 이사는 725 주의 보통주를 제한 주식 단위로 2025-10-15$0로 취득하여 직접적인 혜택 소유를 79,344 주로 증가시켰습니다.

제출 문서는 또한 3,061 주의 새로운 주식 옵션 부여를 $127.52의 행사 가격으로 2025-10-15에 보여주며, 최초 행사 가능일은 2026-10-15, 만료일은 2035-10-14입니다. 기존 옵션 보유는 여러 부여에 걸쳐 지속되며 행사 가격은 $57.20에서 $140.68까지이고 만료는 2035년까지 연장됩니다. RSU 보상은 Amended and Restated 2002 Stock Incentive Plan에 따라 시행됩니다.

Paychex (PAYX) a déclaré une attribution d’actions internes sur le formulaire 4. Un administrateur a acquis 725 actions ordinaires via des unités d’actions restreintes le 15/10/2025 à $0, augmentant la détention bénéficiaire à 79 344 actions directement.

La déposition montre également une nouvelle attribution d’options sur actions pour 3 061 actions à un prix d’exercice de $127,52 le 15/10/2025, exercisable pour la première fois le 15/10/2026 et expirant le 14/10/2035. Les positions existantes d’options demeurent en vigueur sur plusieurs attributions, avec des prix d’exercice allant de $57,20 à $140,68 et des échéances allant jusqu’en 2035. L’allocation RSU est effectuée conformément au Amended and Restated 2002 Stock Incentive Plan.

Paychex (PAYX) meldete eine Insider-Eigentumszuwendung auf Formular 4. Ein Director erwarb 725 Stammaktien über Restricted Stock Units am 15.10.2025 zu $0, wodurch das begünstigte Eigentum direkt auf 79.344 Aktien steigt.

Die Einreichung zeigt auch eine neue Optionen-Zuteilung für 3.061 Aktien zu einem Ausübungspreis von $127,52 am 15.10.2025, erstmals ausübbar am 15.10.2026 und fällig am 14.10.2035. Bestehende Optionsbestände bleiben über mehrere Zuteilungen hinweg bestehen, mit Ausübungspreisen von $57,20 bis $140,68 und Laufzeiten bis 2035. Die RSU-Zuteilung erfolgt gemäß dem Amended and Restated 2002 Stock Incentive Plan.

Paychex (PAYX) أبلغت عن جائزة ملكية داخلية في النموذج 4. قام مدير باكتساب 725 سهماً عادياً من خلال وحدات الأسهم المقيدة في 15/10/2025 بسعر $0، مما زاد الملكية المستفيدة إلى 79,344 سهماً مباشرة.

يظهر الإيداع أيضاً منحة خيار أسهم جديدة لـ 3,061 سهماً بسعر ممارسة $127.52 في 15/10/2025، قابلة للممارسة لأول مرة في 15/10/2026 وتنتهي صلاحيتها في 14/10/2035. تبقى ممتلكات الخيارات الحالية سارية عبر منح متعددة، بأسعار ممارسة تتراوح من $57.20 إلى $140.68 وتواريخ انتهاء حتى 2035. جائزة RSU مقدمة وفقًا لخطة الحوافز على الأسهم المعدلة والمراجعة لعام 2002.

Paychex (PAYX) 在 Form 4 上披露了一项内部股权奖励。董事通过受限股票单位在 2025-10-15$0 价格获得 725 股普通股,直接将受益所有权增加到 79,344 股

filing 还显示了一项新的股票期权授予,数量为 3,061 股,行权价为 $127.52,日期同为 2025-10-15,首次可行使日为 2026-10-15,到期日为 2035-10-14。现有期权持有在多个授予中仍在生效,行权价从 $57.20$140.68,到期日延至 2035。RSU 授予依据经修订及重述的 2002 年股票激励计划

Positive
  • None.
Negative
  • None.

Paychex (PAYX) ha riportato un premio azionario interno su Form 4. Un amministratore ha acquistato 725 azioni ordinarie tramite unità di azioni vincolate il 15/10/2025 a $0, aumentando la proprietà beneficiaria a 79.344 azioni direttamente.

La presentazione mostra anche una nuova assegnazione di opzione su azioni per 3.061 azioni a un prezzo di esercizio di $127,52 il 15/10/2025, primo esercizio il 15/10/2026 e scadenza il 14/10/2035. Le attuali posizioni in opzioni rimangono in essere su più premi, con prezzi di esercizio che vanno da $57,20 a $140,68 e scadenze fino al 2035. L’assegnazione RSU è conforme al Amended and Restated 2002 Stock Incentive Plan.

Paychex (PAYX) informó una adjudicación de acciones de insider en el Formulario 4. Un director adquirió 725 acciones comunes mediante unidades de acciones restringidas el 15/10/2025 a $0, aumentando la propiedad beneficiosa a 79.344 acciones directamente.

La presentación también muestra una nueva adjudicación de opciones sobre acciones por 3.061 acciones a un precio de ejercicio de $127,52 el 15/10/2025, primero ejercitable el 15/10/2026 y venciendo el 14/10/2035. Las tenencias existentes de opciones permanecen vigentes en múltiples adjudicaciones, con precios de ejercicio que van desde $57,20 hasta $140,68 y vencimientos que se extienden hasta 2035. El premio RSU se otorga de conformidad con el Amended and Restated 2002 Stock Incentive Plan.

Paychex (PAYX)가 Form 4에서 내부 주식 보상을 보고했습니다. 이사는 725 주의 보통주를 제한 주식 단위로 2025-10-15$0로 취득하여 직접적인 혜택 소유를 79,344 주로 증가시켰습니다.

제출 문서는 또한 3,061 주의 새로운 주식 옵션 부여를 $127.52의 행사 가격으로 2025-10-15에 보여주며, 최초 행사 가능일은 2026-10-15, 만료일은 2035-10-14입니다. 기존 옵션 보유는 여러 부여에 걸쳐 지속되며 행사 가격은 $57.20에서 $140.68까지이고 만료는 2035년까지 연장됩니다. RSU 보상은 Amended and Restated 2002 Stock Incentive Plan에 따라 시행됩니다.

Paychex (PAYX) a déclaré une attribution d’actions internes sur le formulaire 4. Un administrateur a acquis 725 actions ordinaires via des unités d’actions restreintes le 15/10/2025 à $0, augmentant la détention bénéficiaire à 79 344 actions directement.

La déposition montre également une nouvelle attribution d’options sur actions pour 3 061 actions à un prix d’exercice de $127,52 le 15/10/2025, exercisable pour la première fois le 15/10/2026 et expirant le 14/10/2035. Les positions existantes d’options demeurent en vigueur sur plusieurs attributions, avec des prix d’exercice allant de $57,20 à $140,68 et des échéances allant jusqu’en 2035. L’allocation RSU est effectuée conformément au Amended and Restated 2002 Stock Incentive Plan.

Paychex (PAYX) meldete eine Insider-Eigentumszuwendung auf Formular 4. Ein Director erwarb 725 Stammaktien über Restricted Stock Units am 15.10.2025 zu $0, wodurch das begünstigte Eigentum direkt auf 79.344 Aktien steigt.

Die Einreichung zeigt auch eine neue Optionen-Zuteilung für 3.061 Aktien zu einem Ausübungspreis von $127,52 am 15.10.2025, erstmals ausübbar am 15.10.2026 und fällig am 14.10.2035. Bestehende Optionsbestände bleiben über mehrere Zuteilungen hinweg bestehen, mit Ausübungspreisen von $57,20 bis $140,68 und Laufzeiten bis 2035. Die RSU-Zuteilung erfolgt gemäß dem Amended and Restated 2002 Stock Incentive Plan.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
VELLI JOSEPH M

(Last) (First) (Middle)
911 PANORAMA TRAIL SOUTH

(Street)
ROCHESTER NY 14625

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PAYCHEX INC [ PAYX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/15/2025 A 725(1) A $0 79,344 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $127.52 10/15/2025 A 3,061 10/15/2026 10/14/2035 Common Stock 3,061 $127.52 3,061 D
Stock Option $60.59 07/07/2017 07/06/2026 Common Stock 10,220 10,220 D
Stock Option $57.2 07/13/2018 07/12/2027 Common Stock 9,615 9,615 D
Stock Option $70.37 07/12/2019 07/11/2028 Common Stock 8,641 8,641 D
Stock Option $85.33 07/11/2020 07/10/2029 Common Stock 7,929 7,929 D
Stock Option $73.53 07/15/2021 07/14/2030 Common Stock 5,793 5,793 D
Stock Option $112.67 07/15/2022 07/14/2031 Common Stock 5,075 5,075 D
Stock Option $115 07/15/2023 07/14/2032 Common Stock 3,027 3,027 D
Stock Option $120.86 07/15/2024 07/14/2033 Common Stock 3,382 3,382 D
Stock Option $121.63 07/15/2025 07/14/2034 Common Stock 3,351 3,351 D
Stock Option $140.68 07/15/2026 07/14/2035 Common Stock 670 670 D
Explanation of Responses:
1. Award of restricted stock units, subject to vesting, pursuant to the Amended and Restated 2002 Stock Incentive Plan.
Prabha S. Bhandari, Attorney-in-fact 10/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PAYX disclose in this Form 4?

A director reported receiving 725 RSUs on 10/15/2025 at $0 and a new stock option grant for 3,061 shares at $127.52.

How many PAYX shares does the reporting person own after the transaction?

Beneficial ownership is 79,344 shares directly following the reported transactions.

What are the terms of the new PAYX stock option grant?

Options for 3,061 shares at $127.52, first exercisable on 10/15/2026, expiring on 10/14/2035.

Was the PAYX equity award part of a stock plan?

Yes. The 725 RSUs were awarded pursuant to the Amended and Restated 2002 Stock Incentive Plan.

What other PAYX options are outstanding for the insider?

Multiple grants remain outstanding, with exercise prices from $57.20 to $140.68 and expirations through 2035.

What is the insider’s role at PAYX?

The reporting person is a Director of Paychex, Inc.
Paychex Inc

NASDAQ:PAYX

PAYX Rankings

PAYX Latest News

PAYX Latest SEC Filings

PAYX Stock Data

45.52B
321.70M
10.62%
81.49%
3.52%
Software - Application
Services-engineering, Accounting, Research, Management
Link
United States
ROCHESTER